Qinghai Ye Selected Research

Qinghai Ye Research Topics

Disease

19	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 03/2008
18	Neoplasms (Cancer) 02/2024 - 03/2009
12	Neoplasm Metastasis (Metastasis) 12/2023 - 12/2010
5	Liver Neoplasms (Liver Cancer) 01/2022 - 03/2009
4	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 03/2016
3	Cholangiocarcinoma 01/2022 - 01/2021
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 02/2024
1	Thrombosis (Thrombus) 12/2023
1	Adenocarcinoma 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Glioma (Gliomas) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Proteinuria 01/2020
1	Endometrial Neoplasms (Endometrial Cancer) 01/2020
1	Disease Progression 03/2016
1	Hepatitis B 12/2010
1	Fibrosis (Cirrhosis) 02/2004

Drug/Important Bio-Agent (IBA)

5	Messenger RNA (mRNA)IBA 10/2022 - 02/2004
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 03/2008
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2018 - 03/2008
2	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 02/2016
2	WW Domain-Containing OxidoreductaseIBA 07/2018 - 01/2018
2	OsteopontinIBA 03/2016 - 04/2014
2	Epithelial Cell Adhesion MoleculeIBA 03/2009 - 03/2008
1	CateninsIBA 02/2024
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2023
1	Circulating Tumor DNAIBA 12/2023
1	Glucose (Dextrose)FDA LinkGeneric 10/2022
1	shikoninIBA 10/2022
1	Complement C5 (Complement 5)IBA 10/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	pembrolizumabIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	NivolumabIBA 01/2022
1	camrelizumabIBA 01/2022
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2021
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	Leucovorin (Folinic Acid)FDA Link 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	ChemokinesIBA 01/2020
1	Glycogen Synthase KinasesIBA 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 01/2019
1	AntibodiesIBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	ARQ 197IBA 01/2019
1	capmatinibIBA 01/2019
1	Disulfiram (Antabuse)FDA Link 01/2019
1	CopperIBA 01/2019
1	LigandsIBA 01/2019
1	TOR Serine-Threonine KinasesIBA 12/2017
1	Adenosine Monophosphate (AMP)IBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 01/2017
1	EnzymesIBA 01/2017
1	SirtuinsIBA 01/2017
1	VimentinIBA 03/2016
1	Cetuximab (Erbitux)FDA Link 03/2016
1	PlatinumIBA 02/2016
1	elemeneIBA 02/2016
1	DNA AdductsIBA 02/2016
1	Copper Transporter 1IBA 02/2016
1	Plant ExtractsIBA 02/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2013
1	CytokinesIBA 12/2010
1	Interleukin-2 (IL2)IBA 12/2010
1	Interleukin-15 (Interleukin 15)IBA 12/2010
1	beta CateninIBA 03/2009
1	Complementary DNA (cDNA)IBA 02/2004

Therapy/Procedure

7	Therapeutics 02/2024 - 03/2016
5	Immunotherapy 02/2024 - 12/2017
3	Hepatectomy 12/2023 - 04/2016
2	Drug Therapy (Chemotherapy) 01/2023 - 03/2016
2	Neoadjuvant Therapy 01/2022 - 01/2014
1	Transplantation 02/2016
1	Chemoprevention 02/2004